Our membership integrates clinician-prescribed medication, personalized dosing, 1:1 coaching, and biomarker tracking to support muscle preservation, cardiometabolic health, and long-term outcomes
The notion that GLP-1 analogues may affect feeding even when they do not enter the brain is supported by studies showing that large molecular size GLP-1 receptor agonists (albumin-conjugated GLP-1 receptor agonists), that cannot cross the blood-brain barrier can inhibit feeding in both humans and mice
Some people have a tendency to break down medications more quickly than others
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia
The compounded semaglutide guide covers pricing, sourcing, and quality considerations
By week 4-5, most people have minimal nausea